Ignite Creation Date:
2024-05-06 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 2:19 PM
Study NCT ID:
NCT05143996
Status:
RECRUITING
Last Update Posted:
2023-12-27
First Post:
2021-10-26
Brief Title:
CLN-049 in Patients With RelapsedRefractory Acute Myeloid Leukemia AML or Myelodysplastic Syndrome MDS
Sponsor:
Cullinan Therapeutics Inc
Organization:
Cullinan Therapeutics Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndrome MDS |
| RelapsedRefractory Acute Myeloid Leukemia AML |
Keywords: